BRAINSTORM CELL THERAPEUTICS

CUSIP: 10501E201 Class: COM NEW

Weaver Consulting Group's Holding History (CIK: 0001780055)

Note: Option positions (PUT/CALL) are excluded.

Q4 2024
Shares 15,623 Value ($000) $35 Avg Close — Range —
Q3 2024
Shares 234,356 Value ($000) $54 Avg Close — Range —
Q2 2024
Shares 234,356 Value ($000) $79 Avg Close — Range —
Q1 2024
Shares 199,356 Value ($000) $113 Avg Close — Range —
Q4 2023
Shares 199,356 Value ($000) $54 Avg Close — Range —
Q3 2023
Shares 99,356 Value ($000) $20 Avg Close — Range —
Q2 2023
Shares 64,713 Value ($000) $133 Avg Close — Range —
Q1 2023
Shares 63,713 Value ($000) $210 Avg Close — Range —
Q4 2022
Shares 65,947 Value ($000) $108 Avg Close — Range —
Q3 2022
Shares 93,972 Value ($000) $415 Avg Close — Range —
Q2 2022
Shares 104,653 Value ($000) $289 Avg Close — Range —
Q1 2022
Shares 130,000 Value ($000) $437 Avg Close — Range —
Q4 2021
Shares 155,500 Value ($000) $622 Avg Close — Range —
Q3 2021
Shares 51,500 Value ($000) $170 Avg Close — Range —
Q2 2021
Shares 48,881 Value ($000) $186 Avg Close — Range —
Q1 2021
Shares 50,000 Value ($000) $192 Avg Close — Range —